- Home
- LIXT vs XWEL Comparison
LIXT vs XWEL Comparison
Compare LIXT & XWEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LIXT
- XWEL
- Stock Information
- Founded
- LIXT 2005
- XWEL 2006
- Country
- LIXT United States
- XWEL United States
- Employees
- LIXT N/A
- XWEL N/A
- Industry
- LIXT Biotechnology: Pharmaceutical Preparations
- XWEL Other Consumer Services
- Sector
- LIXT Health Care
- XWEL Consumer Discretionary
- Exchange
- LIXT Nasdaq
- XWEL Nasdaq
- Market Cap
- LIXT 4.1M
- XWEL 4.1M
- IPO Year
- LIXT N/A
- XWEL N/A
- Fundamental
- Price
- LIXT $1.24
- XWEL $0.78
- Analyst Decision
- LIXT
- XWEL
- Analyst Count
- LIXT 0
- XWEL 0
- Target Price
- LIXT N/A
- XWEL N/A
- AVG Volume (30 Days)
- LIXT 8.5K
- XWEL 56.6K
- Earning Date
- LIXT 05-08-2025
- XWEL 04-15-2025
- Dividend Yield
- LIXT N/A
- XWEL N/A
- EPS Growth
- LIXT N/A
- XWEL N/A
- EPS
- LIXT N/A
- XWEL N/A
- Revenue
- LIXT N/A
- XWEL $33,897,000.00
- Revenue This Year
- LIXT N/A
- XWEL N/A
- Revenue Next Year
- LIXT N/A
- XWEL N/A
- P/E Ratio
- LIXT N/A
- XWEL N/A
- Revenue Growth
- LIXT N/A
- XWEL 12.58
- 52 Week Low
- LIXT $1.02
- XWEL $0.70
- 52 Week High
- LIXT $3.50
- XWEL $2.70
- Technical
- Relative Strength Index (RSI)
- LIXT 50.56
- XWEL 42.51
- Support Level
- LIXT $1.10
- XWEL $0.73
- Resistance Level
- LIXT $1.35
- XWEL $0.85
- Average True Range (ATR)
- LIXT 0.11
- XWEL 0.12
- MACD
- LIXT 0.02
- XWEL 0.00
- Stochastic Oscillator
- LIXT 62.40
- XWEL 25.77
About LIXT Lixte Biotechnology Holdings Inc.
Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.
About XWEL XWELL Inc.
XWELL Inc is a health and wellness holding company. It is an airport retailer of spa services through XpresSpa locations, offering travelers premium spa services, including massage, nail, and skincare, as well as spa and travel products. It operates four reportable operating segments: XpresSpa. XpresTest, Naples Wax Center and Treat. XpresSpa provides travelers premium spa services, including massage, nail and skin care, as well as spa and travel products.. Treat is a travel health and wellness brand that offers in-airport spa. XpresTest provides COVID-19 screening and diagnostic testing in partnership with the CDC. Naples Wax Center operates three high-performing locations with core products and service offerings from face and body waxing to a range of skincare and cosmetic products.